Conclusion: IP regimen can achieve a satisfied results in the treatment of recurrent and refractory Non-Hodgkin's lymphoma with well tolerated toxicity.
结论:IP方案治疗复发和难治性非霍奇金淋巴瘤的疗效比较满意,其毒性能够耐受,经对症处理均能恢复。
2
Purpose: To study the salvage treatment of recurrent intermediate-high grade non Hodgkin lymphoma (NHL).
目的:研究复发性中高度非霍奇金淋巴瘤的解救治疗。
3
Objective: to observe the efficacy and the side effect of ESHAP in the treatment of refractory or recurrentNon-Hodgkin's lymphoma (NHL).